Pharma IQ spoke to Bhuvaneish T. Selvaraj, a Post Doctorate Fellow in neurodegenerative disorders, to discover more about his ongoing CRISPR Cas9 project.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
April 20-21, 2026
The Logan, Philadelphia, USA
Register Now |
View Agenda |
Learn More